Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | V1034I |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TSC2 V1034I does not lie within any known functional domains of the Tsc2 protein (UniProt.org). V1034I has been identified in sequencing studies (PMID: 27930734), but has not been biochemically characterized and therefore, its effect on Tsc2 protein function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 V1034I |
Transcript | NM_000548.5 |
gDNA | chr16:g.2079165G>A |
cDNA | c.3100G>A |
Protein | p.V1034I |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000548.4 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001114382 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001318832 | chr16:g.2079343G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
XM_011522636 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001318832.2 | chr16:g.2079343G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001318832.1 | chr16:g.2079343G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_000548 | chr16:g.2079165G>A | c.3100G>A | p.V1034I | RefSeq | GRCh38/hg38 |
NM_001406667.1 | chr16:g.2079283_2079285delGTGinsATC | c.3100_3102delGTGinsATC | p.V1034I | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|